4//SEC Filing
O'Hara Elaine 4
Accession 0001209191-23-015688
CIK 0001000694other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:02 PM ET
Size
8.2 KB
Accession
0001209191-23-015688
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
O'Hara Elaine
EVP, Chief Strategy Officer
Transactions
- Award
Stock Option (Right to buy)
2023-03-01+67,900→ 67,900 totalExercise: $6.86From: 2024-03-01Exp: 2033-03-01→ Common Stock (67,900 underlying) - Award
Restricted Stock Units
2023-03-01+58,800→ 58,800 total→ Common Stock (58,800 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") 2023 Inducement Plan (the "Plan") will vest on the first anniversary of the March 1, 2023 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
- [F3]The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001968045
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:02 PM ET
- Size
- 8.2 KB